SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories informs about outcome of board meeting

29 May 2021 Evaluate

Zim Laboratories has informed that the Board of Directors in their meeting held today has considered and approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2021 and the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2021 (prepared pursuant to SEBI (LODR) Regulations, 2015. Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditor's report with an unmodified opinion on the financial results for the year ended 31.03.2021 which is enclosed. The Board Meeting commenced at 11:45 am and concluded at 01:30 pm.

The above information is a part of company’s filings submitted to BSE.


Zim Laboratories Share Price

79.72 3.72 (4.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×